date:May 26, 2012
bstances in a randomized double-blind placebo-controlled trial with 443 Swedish citizens aged between 70 and 88 (228 participants completed the study).
Participants were randomly assigned to receive either 200 mg per day of coenzyme Q10 capsules (Bio-Quinon, Pharma Nord, Denmark) and 200 micrograms per day of organic selenium yeast tablets (SelenoPrecise, Pharma Nord, Denmark), or similar placebo for 48 months.
Results showed that 12.6% of people in the placebo group died of cardiovascular dis